3 CRC cells were plated in 60-mm culture dishes (or 2×10 2 in 6-well plates) and incubated at 37°C. After overnight incubation, treatments were added and incubated for 2 weeks. The clones were fixed with methanol for 2 minutes, stained with 0.5% crystal violet and incubated at room temperature for 20 minutes. The cells were washed to remove staining exceeded. Colonies were defined from counts of at least 50 cells.
Immunofluorescence staining
The cells were seeded in coverslip slides on 6-well plates, fixed with paraformaldehyde (PFA) 4% for 20 minutes and washed 3 times with PBS 1×, permeabilized with PBS 1× 0.1% Triton X-100 at room temperature for 5 minutes and blocked with BSA 2% for 45 minutes-2 hours. Cells were incubated with primary antibody in BSA 2% in a dilution 1:50 overnight and then incubated with 1:200 fluorescence secondary antibody in BSA 2% for 1 hour at room temperature. Coverslip slides were mounted in VectaShield with DAPI (Vector Laboratories, Burlingame, USA).
Western blot analysis
Cells were plated onto different dishes at a density of 70% cells per dish and then treated according to the experimental design. After washing the cultures with PBS, cells were lysed with RIPA buffer.
Protein concentration was determined by the BCA Protein Assay (Pierce, Rockford, IL, USA). 30 μg of the protein extract was subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), and transferred to PVDF membranes. After blocking for 1 hour with 5% dried non-fat milk in TBS 1× -Tween 0.1%, the membranes were incubated with primary antibody diluted 1:1000 in 1% bovine serum albumin (BSA) in TBS 1× -Tween 0.1%. Antibody binding was detected using a secondary antibody diluted 1:2000 in TBS 1× -Tween 0.1% and an enhanced chemiluminescence (ECL) detection kit (Amersham, Buckinghamshire, UK). α-tubulin expression was used as an endogenous control. A general protocol for nuclear and cytosolic fractions separation was used.
Cell death assessment
In order to assess necrosis or apoptosis by flow cytometry and immunofluorescence, cells were stained with the Promokine apoptotic/necrotic/healthy cell detection kit (cat #PK-CA707-30018, PromoCell, Heidelberg, Germany). First, the cells were detached from the cell culture plate using StemPro Accutase Cell Dissociation Reagent (cat #A1110501, Thermo Scientific), washed twice with 1X binding buffer and then incubated for 15 minutes at room temperature with staining solution (5 μL of FITC-Annexin V, 5 μL of Ethidium Homodimer III and 5 μL of Hoechst 33342 to 100 μL of 1× binding buffer). Cells were washed 1-2 times and mounted on a slide for microscope viewing, or resuspended in 400 μL in 1× binding buffer and then sent for flow cytometry analysis within 1 hour of staining in a Gallios Flow Cytometer (Beckman Coulter, Krefeld, Germany).
The Ac-DEVD-AMC Caspase-3 fluorogenic assay (BD Biosciences Pharmingen, San Agustin de Guadalix, Madrid, Spain) was performed to assess caspase-dependent apoptosis. Whole cellular extract (adherent cells and floating cells) was recovered with lysis buffer and, subsequently, 20 μM of Ac-DEVD-AMC and the cell lysate were replaced by 1 mL of protease assay buffer (described in the manufacturer's instructions). The reaction mixtures were incubated for 2 hours at 37°C in the dark and then measured at wavelengths of 380 nm excitation and 430-460 nm emission.
Immunofluorescence of cleaved caspase 3 was also carried out.
AKT inhibition by oral allosteric MK2206 inhibitor and P38 by VX-702 selective P38α inhibitor
MK-2206 2HCl and VX-702 were purchased from Selleck Chemicals (Houston, TX, USA) and dissolved in DMSO as a stock solution. CRC cells were seeded at a density of 2000/4000 cells per well in 96-well plates and incubated with DMEMF12 overnight. Inhibitors were then added to the cells in combination with 5FU or oxaliplatin. Cell proliferation was determined after 5 days by the WST-1 proliferation assay. The effect of the drug on each cell line in the presence or absence of inhibitors was calculated by normalizing the cell frequency after 5 days of continuous treatment with respect to the maximum frequency of cells in each treatment. Western blot was performed to confirm inhibition of pAKT Ser473 in colorectal cell lines. 
